C116H127F15N30O10S5 — CID 157214176
3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclobutan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine (PubChem CID 157214176) has the molecular formula C116H127F15N30O10S5 and a molecular weight of 2546.80 g/mol. Its IUPAC name is 3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclobutan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine.
| Compound Name | 3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclobutan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine |
|---|---|
| PubChem CID | 157214176 |
| Molecular Formula | C116H127F15N30O10S5 |
| Molecular Weight | 2546.80 g/mol |
| Exact Mass | 2544.87 |
| IUPAC Name | 3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclobutan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclohexan-1-amine;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine;3-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]cyclopentan-1-amine |
| SMILES | CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CC(N)C4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CCC(N)C4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CCC(N)CC4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CCCC(N)C4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CCCC4N)C3)cc2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/2C24H27F3N6O2S.2C23H25F3N6O2S.C22H23F3N6O2S/c1-36(34,35)22-20(24(25,26)27)11-10-19(21(22)23-29-31-32-30-23)15-4-2-14(3-5-15)16-12-33(13-16)18-8-6-17(28)7-9-18;1-36(34,35)22-20(24(25,26)27)10-9-19(21(22)23-29-31-32-30-23)15-7-5-14(6-8-15)16-12-33(13-16)18-4-2-3-17(28)11-18;1-35(33,34)21-19(23(24,25)26)9-8-18(20(21)22-28-30-31-29-22)14-4-2-13(3-5-14)15-11-32(12-15)17-7-6-16(27)10-17;1-35(33,34)21-17(23(24,25)26)10-9-16(20(21)22-28-30-31-29-22)14-7-5-13(6-8-14)15-11-32(12-15)19-4-2-3-18(19)27;1-34(32,33)20-18(22(23,24)25)7-6-17(19(20)21-27-29-30-28-21)13-4-2-12(3-5-13)14-10-31(11-14)16-8-15(26)9-16/h2-5,10-11,16-18H,6-9,12-13,28H2,1H3,(H,29,30,31,32);5-10,16-18H,2-4,11-13,28H2,1H3,(H,29,30,31,32);2-5,8-9,15-17H,6-7,10-12,27H2,1H3,(H,28,29,30,31);5-10,15,18-19H,2-4,11-12,27H2,1H3,(H,28,29,30,31);2-7,14-16H,8-11,26H2,1H3,(H,27,28,29,30) |
| InChIKey | ASFLEOUGMPZBHB-UHFFFAOYSA-N |
| XLogP | 16.57 |
| TPSA | 589.30 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2546.80 |
| LogP ≤ 5 | 16.57 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 35 |